Savara (SVRA) Amortization of Deferred Charges (2015 - 2026)
Savara (SVRA) reported Amortization of Deferred Charges of $160000.0 for Q1 2026, up 128.57% year-over-year from $70000.0 in Q1 2025, and up 26.98% on a QoQ basis from $126000.0 in Q4 2025.
Savara (SVRA) has 12 years of Amortization of Deferred Charges data on file, last reported at $160000.0 in Q1 2026.
- Quarterly Amortization of Deferred Charges rose 128.57% year-over-year to $160000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $543000.0 (up 98.9% YoY) and the FY2025 annual result came in at $453000.0, up 67.16% from the prior year.
- Amortization of Deferred Charges improved to $160000.0 in Q1 2026 per SVRA's latest filing, from $126000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $160000.0 in Q1 2026 and bottomed at $45000.0 in Q2 2022.
- The 5-year median for Amortization of Deferred Charges is $68000.0 (2022), against an average of $87588.2.
- The widest annual swing landed in 2022, when Amortization of Deferred Charges slumped 67.15%; it then surged 128.57% in 2026.
- Tracing SVRA's Amortization of Deferred Charges over 5 years: stood at $68000.0 in 2022, then changed by 0.0% to $68000.0 in 2023, then changed by 0.0% to $68000.0 in 2024, then soared by 85.29% to $126000.0 in 2025, then grew by 26.98% to $160000.0 in 2026.
- Per Business Quant, the three latest SVRA Amortization of Deferred Charges figures stand at $160000.0 (Q1 2026), $126000.0 (Q4 2025), and $128000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 160,000.00 |
| Mar 31, 2026 | 160,000.00 |
| Dec 31, 2025 | 126,000.00 |
| Dec 31, 2025 | 126,000.00 |
| Sep 30, 2025 | 128,000.00 |
| Sep 30, 2025 | 128,000.00 |
| Jun 30, 2025 | 129,000.00 |
| Jun 30, 2025 | 129,000.00 |
| Mar 31, 2025 | 70,000.00 |
| Mar 31, 2025 | 70,000.00 |
| Dec 31, 2024 | 68,000.00 |
| Dec 31, 2024 | 68,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Jun 30, 2024 | 67,000.00 |
| Jun 30, 2024 | 67,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Sep 30, 2023 | 68,000.00 |
| Sep 30, 2023 | 68,000.00 |
| Jun 30, 2023 | 67,000.00 |
| Jun 30, 2023 | 67,000.00 |
| Mar 31, 2023 | 68,000.00 |
| Mar 31, 2023 | 68,000.00 |
| Dec 31, 2022 | 68,000.00 |
| Dec 31, 2022 | 68,000.00 |
| Sep 30, 2022 | 68,000.00 |
| Sep 30, 2022 | 68,000.00 |
| Jun 30, 2022 | 45,000.00 |
| Jun 30, 2022 | 45,000.00 |
| Mar 31, 2022 | 153,000.00 |
| Mar 31, 2022 | 153,000.00 |
| Dec 31, 2021 | 139,000.00 |
| Dec 31, 2021 | 139,000.00 |
| Sep 30, 2021 | 136,000.00 |
| Sep 30, 2021 | 136,000.00 |
| Jun 30, 2021 | 137,000.00 |
| Jun 30, 2021 | 137,000.00 |
| Mar 31, 2021 | 140,000.00 |
| Mar 31, 2021 | 140,000.00 |
| Dec 31, 2020 | 126,000.00 |
| Dec 31, 2020 | 126,000.00 |
| Sep 30, 2020 | 122,000.00 |
| Sep 30, 2020 | 122,000.00 |
| Jun 30, 2020 | 125,000.00 |
| Jun 30, 2020 | 125,000.00 |
| Mar 31, 2020 | 134,000.00 |
| Mar 31, 2020 | 134,000.00 |
| Dec 31, 2019 | 150,000.00 |
| Dec 31, 2019 | 150,000.00 |
| Sep 30, 2019 | 140,000.00 |
| Sep 30, 2019 | 140,000.00 |
| Jun 30, 2019 | 145,000.00 |
| Jun 30, 2019 | 145,000.00 |
| Mar 31, 2019 | 147,000.00 |
| Mar 31, 2019 | 147,000.00 |
| Dec 31, 2018 | 136,000.00 |
| Dec 31, 2018 | 136,000.00 |
| Sep 30, 2018 | 109,000.00 |
| Sep 30, 2018 | 109,000.00 |
| Jun 30, 2018 | 114,000.00 |
| Jun 30, 2018 | 114,000.00 |
| Mar 31, 2018 | 109,000.00 |
| Mar 31, 2018 | 109,000.00 |
| Dec 31, 2017 | 6,000.00 |
| Dec 31, 2017 | 6,000.00 |
| Sep 30, 2017 | 191,000.00 |
| Sep 30, 2017 | 191,000.00 |
| Jun 30, 2017 | 106,000.00 |
| Jun 30, 2017 | 106,000.00 |
| Mar 31, 2017 | 98,000.00 |
| Mar 31, 2017 | 98,000.00 |
| Dec 31, 2016 | 100,000.00 |
| Dec 31, 2016 | 100,000.00 |
| Sep 30, 2016 | 73,000.00 |
| Sep 30, 2016 | 73,000.00 |
| Jun 30, 2016 | -143,000.00 |
| Jun 30, 2016 | -143,000.00 |
| Mar 31, 2016 | 169,000.00 |
| Mar 31, 2016 | 169,000.00 |
| Dec 31, 2015 | 613,000.00 |
| Dec 31, 2015 | 613,000.00 |